Search Results - "HEPKEMA, Bouke G"

Refine Results
  1. 1

    Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma by Jiang, Peijia, Nolte, Ilja M, Hepkema, Bouke G, Stulp, Marijke, van den Berg, Anke, Diepstra, Arjan

    Published in Frontiers in immunology (27-01-2022)
    “…Tumor cells of classic Hodgkin lymphoma (cHL) are derived from antigen presenting B cells that are infected by Epstein Barr virus (EBV) in ~30% of patients…”
    Get full text
    Journal Article
  2. 2

    Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies by Lammerts, Rosa G M, Altulea, Dania, Hepkema, Bouke G, Sanders, Jan-Stephan, van den Born, Jacob, Berger, Stefan P

    Published in Frontiers in immunology (06-05-2022)
    “…To date, human leukocyte antigens (HLA) have been the major focus in the approach to acute and chronic antibody-mediated rejection (AMBR) in solid-organ…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Renal Endothelial Cytotoxicity Assay to Diagnose and Monitor Renal Transplant Recipients for Anti-Endothelial Antibodies by Lammerts, Rosa G. M., Born, Jacob van den, Huberts-Kregel, Magdalena, Gomes-Neto, Antonio W., Daha, Mohammed R., Hepkema, Bouke G., Sanders, Jan-Stephan, Pol, Robert A., Diepstra, Arjan, Berger, Stefan P.

    Published in Frontiers in immunology (06-06-2022)
    “…Tissue-specific nonhuman leukocyte antigen (HLA) antigens can play crucial roles in allograft immunity and have been shown to trigger humoral responses leading…”
    Get full text
    Journal Article
  5. 5

    Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney by Tiller, Gesa, Lammerts, Rosa G M, Karijosemito, Jessy J, Alkaff, Firas F, Diepstra, Arjan, Pol, Robert A, Meter-Arkema, Anita H, Seelen, Marc A, van den Heuvel, Marius C, Hepkema, Bouke G, Daha, Mohamed R, van den Born, Jacob, Berger, Stefan P

    Published in Frontiers in immunology (13-04-2022)
    “…The role of the complement system in antibody-mediated rejection (ABMR) is insufficiently understood. We aimed to investigate the role of local and systemic…”
    Get full text
    Journal Article
  6. 6

    HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients by Fletcher, Luke B, Veenstra, Rianne N, Loo, Eric Y, Hwang, Amie E, Siddiqi, Imran N, Visser, Lydia, Hepkema, Bouke G, Nolte, Ilja M, van den Berg, Anke, Cozen, Wendy, Diepstra, Arjan

    Published in PloS one (23-03-2017)
    “…A proportion of classical Hodgkin lymphomas harbor the Epstein Barr virus (EBV). We previously demonstrated that associations between Human Leukocyte Antigen…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression by Habets, Thomas H P M, Hepkema, Bouke G, Kouprie, Niels, Schnijderberg, Melanie C A, van Smaalen, Tim C, Bungener, Laura B, Christiaans, Maarten H L, Bos, Gerard M J, Vanderlocht, Joris

    Published in PloS one (07-09-2018)
    “…Human leukocyte antigen (HLA)-DRB3 is a functional HLA class II gene, which has a limited allele diversity in the human population. Furthermore, the HLA-DRB3…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    UMOD as a susceptibility gene for end-stage renal disease by Reznichenko, Anna, Böger, Carsten A, Snieder, Harold, van den Born, Jacob, de Borst, Martin H, Damman, Jeffrey, van Dijk, Marcory C R F, van Goor, Harry, Hepkema, Bouke G, Hillebrands, Jan-Luuk, Leuvenink, Henri G D, Niesing, Jan, Bakker, Stephan J L, Seelen, Marc, Navis, Gerjan

    Published in BMC genetics (05-09-2012)
    “…In recent genetic association studies, common variants including rs12917707 in the UMOD locus have shown strong evidence of association with eGFR, prevalent…”
    Get full text
    Journal Article
  12. 12

    CUBN as a novel locus for end-stage renal disease: insights from renal transplantation by Reznichenko, Anna, Snieder, Harold, van den Born, Jacob, de Borst, Martin H, Damman, Jeffrey, van Dijk, Marcory C R F, van Goor, Harry, Hepkema, Bouke G, Hillebrands, Jan-Luuk, Leuvenink, Henri G D, Niesing, Jan, Bakker, Stephan J L, Seelen, Marc, Navis, Gerjan

    Published in PloS one (04-05-2012)
    “…Chronic kidney disease (CKD) is a complex disorder. As genome-wide association studies identified cubilin gene CUBN as a locus for albuminuria, and urinary…”
    Get full text
    Journal Article
  13. 13
  14. 14

    HLA‐B51:197: A composite product of interlocus recombination of B51:01:01:01 and C01:02:01:01 by Kouprie, Niels, Bungener, Laura B., Lambeck, Annechien J. A., Kroesen, Bart‐Jan, Hepkema, Bouke G.

    Published in HLA (01-07-2024)
    “…The HLA‐B*51:197 allele is generated from the interlocus recombination of both HLA‐B*51:01:01:01 and HLA‐C*01:02:01:01 alleles…”
    Get full text
    Journal Article
  15. 15

    CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients by Muntinghe, Friso L H, Abdulahad, Wayel H, Huitema, Minke G, Damman, Jeffrey, Seelen, Marc A, Lems, Simon P M, Hepkema, Bouke G, Navis, Gerjan, Westra, Johanna

    Published in PloS one (13-02-2012)
    “…In patients with end stage renal disease (ESRD) we observed protection from inflammation-associated mortality in CCR5Δ32 carriers, leading to CCR5 deficiency,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Pretransplant NT-proBNP, Dialysis Vintage, and Posttransplant Mortality in Kidney Transplant Recipients by Yeung, Stanley M.H., van Londen, Marco, Nakshbandi, Uzma, Said, M. Yusof, Eisenga, Michele F., Hepkema, Bouke G., Nolte, Ilja M., Berger, Stefan P., de Borst, Martin H., Bakker, Stephan J.L.

    Published in Transplantation (01-10-2020)
    “…BACKGROUND.End-stage kidney disease and dialysis vintage are characterized by accelerated atherosclerosis, volume overload, and progressive left ventricular…”
    Get full text
    Journal Article